Results 171 to 180 of about 5,101 (183)

The birth and postnatal development of purinergic signalling

Acta Physiologica, 2010
B B Fredholm
exaly  

Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future

BioEssays, 2012

exaly  

Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system

British Journal of Pharmacology, 2009
Markus Van Der Giet, Harald Mischak, Joachim Jankowski   +2 more
exaly  

Purinergic Signalling and Neurological Diseases: An Update

CNS and Neurological Disorders - Drug Targets, 2017

exaly  

Activation of Purinergic Receptors Triggers Oscillatory Contractions in Adult Rat Ventricular Myocytes

Circulation Research, 1996
Bin-Xian Zhang, B K Mcconnell, Derek S Damron   +2 more
exaly  

ALTERATIONS IN CHOLINERGIC AND PURINERGIC SIGNALING IN A MODEL OF THE OBSTRUCTED BLADDER

Journal of Urology, 2001
C S Thompson, D P Mikhailidis, R J Morgan   +2 more
exaly  

Therapeutic potential of purinergic signalling for diseases of the urinary tract

BJU International, 2011

exaly  

Exclusive patent, know-how, process and technology license, including improvements, to develop, use, manufacture, register, market, sell, package, label and sublicense ophthalmic formulations that contain P1,P4-Di(Uridine 5'-Tetraphosphate), based on purinergic receptor agonists, to treat ocular surface diseases in humans, including dry eye.

2000
openaire   +1 more source

Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics

Journal of Advanced Research
Tianqi Mao, Yafei Fang, Yifan Zhu
exaly  

Exclusive patent, know-how, process, technology and trade secret license, including improvements, to develop, use, manufacture, market, sell, package, label and sublicense ophthalmic formulations containing the P1,P4-Di uridine 5'-tetraphosphate compound, based on purinergic receptor agonists, to treat ocular surface diseases in humans, including dry eye.

2000
openaire   +1 more source